OTC:ATXI | Income Statement | AVENUE THERAPEUTICS, INC.

Complete source-backed income-statement history.

Available history
2016-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$0.00$247,000.00$707,000.00-$707,000.00$17,000.00-$690,000.00-$0.213,294,967
2026-03-31$200,000.00-$714,000.00$19,000.00-$695,000.00-$0.213,293,729
2025-12-31$0.00$257,000.00$752,000.00-$752,000.00-$709,000.00-$0.2217,667
2025-09-30$0.00$177,000.00$724,000.00-$724,000.00$32,000.00-$683,000.00-$0.213,183,558
2025-06-30$1.4M$192,000.00$1.11M$297,000.00$32,000.00$335,000.00$0.113,183,558
2025-03-31$411,000.00-$1.91M$47,000.00-$1.85M-$0.622,970,807
2024-12-31$0.00$565,000.00$1.6M-$1.6M-$1.54M$1.48200,027
2024-09-30$0.00$2.33M$3.16M-$3.16M$69,000.00-$3.08M-$1.921,600,189
2024-06-30$0.00$1.36M$2.82M-$2.82M$122,000.00-$2.69M-$6.431,117,769
2024-03-31$2.39M-$3.71M-$641,000.00-$4.34M-$15.40562,031
2023-12-31$982,000.00-$2.12M$529,000.00$42.0745,874
2023-09-30$907,000.00-$2.07M$2.58M$526,000.00$4.86$0.06108,2108,200,069
2023-06-30$3.03M-$3.92M-$93,000.00-$4.01M-$38.74103,442
2023-03-31$1.22M-$6.43M-$1.17M-$7.6M-$101.5774,198
2022-12-31$545,000.00-$3.91M$575,000.00$1.23743,617743,617
2022-09-30$194,000.00-$663,000.00$1,000.00-$662,000.00-$0.45-$0.451,465,6911,465,691
2022-06-30$151,000.00-$605,000.00$1,000.00-$604,000.00-$0.41-$0.0321,916,00521,916,005
2022-03-31$1.81M-$2.86M$2,000.00-$2.86M-$2.05-$0.141,397,14520,957,181
2021-12-31$390,000.00-$914,000.00-$913,000.00$2.33$2.3327,81827,818
2021-09-30$278,000.00-$872,000.00-$871,000.00-$0.79-$0.791,108,4951,108,495
2021-06-30$328,000.00-$951,000.00-$949,000.00-$0.06-$0.0616,556,32016,556,320
2021-03-31$258,000.00-$1M-$998,000.00-$0.06-$0.0616,556,32016,556,320
2020-12-31$484,000.00-$999,000.00-$993,000.00-$0.06-$0.0616,74616,746
2020-09-30$466,000.00-$1.04M-$1.03M-$0.06-$0.0616,519,46416,519,464
2020-06-30$1.22M-$1.9M-$1.89M16,474,655
2020-03-31$697,000.00-$1.27M-$1.24M16,474,655
2019-12-31$3.86M-$5.47M-$5.42M234,100
2019-09-30$1.71M-$2.32M-$2.24M16,376,204
2019-06-30$6.39M-$7.11M-$6.98M16,314,763
2019-03-31$10.24M-$11.36M-$11.27M13,742,649
2018-12-31$2.72M-$4.1M-$3.92M22,703
2018-09-30$1.79M-$2.61M-$2.6M10,295,958
2018-06-30$3.75M-$4.68M-$4.66M10,251,950
2018-03-31$9.44M-$10.43M-$10.38M10,099,331
2017-12-31$4.12M-$6.33M-$6.24M1,119,949
2017-09-30$2M-$2.85M-$2.95M9,972,663
2017-06-30$447,000.00-$1.74M-$2.41M3,459,942
2017-03-31$133,000.00-$504,000.00-$661,000.003,022,846
2016-12-31$163,000.00-$516,000.00-$815,000.0069,852
2016-09-30$183,000.00-$383,000.00-$544,000.002,848,651
2016-06-30$421,000.00-$638,000.00-$771,000.002,785,865
2016-03-31$564,000.00-$840,000.00-$1.05M8,310,604

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$1.4M$1.04M$4.49M-$3.08M$2,000.00-$2.91M-$0.933,131,131
2024-12-31$0.00$6.65M$11.28M-$11.28M$0.00-$11.65M-$15.791,295,207
2023-12-31$6.13M-$14.54M$0.00-$10.49M-$73.48141,222
2022-12-31$2.7M-$8.04M$0.00-$3.55M-$1.632,185,1592,185,159
2021-12-31$1.25M-$3.74M-$3.73M-$0.22-$0.221,133,1701,133,170
2020-12-31$2.87M-$5.21M-$5.15M-$0.31-$0.3116,506,44716,506,447
2019-12-31$22.19M-$26.27M-$25.91M15,721,619
2018-12-31$17.7M-$21.82M-$21.55M10,239,169
2017-12-31$6.7M-$11.42M-$12.26M6,634,937
2016-12-31$1.33M-$2.38M-$3.18M2,860,526